BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5962181)

  • 1. [Ethionamide in the treatment of patients infected with drug resistant bacilli].
    Pregowski W; Zagórecka A
    Pol Tyg Lek; 1966 May; 21(22):833-7. PubMed ID: 5962181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Late results of treatment of patients with drug resistant bacilli with ethionamide and other antitubercular agents].
    Pregowski W; Zagórecka A
    Gruzlica; 1968 Oct; 36(10):1047-9. PubMed ID: 5715457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 6. [The place of the thioamides in the treatment of pulmonary tuberculosis. (Role of TH 1321)].
    Molina C; Cheminat JC; Petit R
    Sem Hop; 1966 Jan; 42(2):99-105. PubMed ID: 4285613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV; Zankisova IG; Poleshchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1971 Nov; 11():79-81. PubMed ID: 5143287
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of antibacterial therapy in patients with fibrocavernous tuberculosis inadequately treated in the past].
    Ianovskaia LM; Tarasova EF; Soldatov VE; Mikhaĭlova MM
    Probl Tuberk; 1969; 47(3):19-23. PubMed ID: 5354629
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of thioamides in primary and post-primary tuberculosis in children with the exclusion of meningitis].
    Gerbeaux J; Baculard A
    Bull Mem Soc Med Hop Paris; 1965 Nov; 116(15):1575-89. PubMed ID: 5295353
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of tuberculosis in diabetics by preparations of the 2d series].
    Radanov R; Dobrev P
    Tuberkuloza; 1967; 19(5):666-7. PubMed ID: 5188403
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 16. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protionamide in the treatment of pulmonary tuberculosis].
    Kalabukha AV; Bialik IB; Mamolat AS
    Vrach Delo; 1972 May; 5():31-3. PubMed ID: 5029793
    [No Abstract]   [Full Text] [Related]  

  • 18. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems of post-sanatorial antimycobacterial treatment].
    Corda M
    Minerva Med; 1965 Sep; 56(70):2827-31. PubMed ID: 5852641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal function in patients with minor forms of pulmonary tuberculosis in the course of treatment with 2d series drugs].
    Stepanenko VA
    Vrach Delo; 1972 Aug; 8():97-8. PubMed ID: 5073195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.